ZYTOMICS Trademark

Trademark Overview


On Wednesday, November 1, 2023, a trademark application was filed for ZYTOMICS with the United States Patent and Trademark Office. The USPTO has given the ZYTOMICS trademark a serial number of 79391171. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Thursday, March 6, 2025. This trademark is owned by ZytoVision GmbH. The ZYTOMICS trademark is filed in the Chemical Products, Pharmaceutical Products, Computer & Software Products & Electrical & Scientific Products, Medical Instrument Products, Advertising, Business and Retail Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Scientific research and laboratory apparatus in the nature of analysis systems for use in the analysis of proteins, nucleic acids, human cells, and human tissues; educational apparatus and simulators in the nature of medical diagnostic simulators for use as teaching aids for medical procedures; analysis apparatus in the nature of diagnostic apparatus for research laboratory use for conducting and evaluating histology, cytology, immunohistology, immunohistochemistry, in situ hybridisation, polymerase chain reaction (PCR), next generation sequencing (NGS), microarray hybridisation in the nature of genetic chip or biochip hybridisation, flow cytometry, and isolation of biomolecules including DNA, RNA and proteins; research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids; analysis apparatus for research laboratories in the nature of diagnostic apparatus for measuring, testing and examining tissue, cells and biomolecules including DNA, RNA and protein...

Pharmaceuticals and medical preparations for use in chemotherapy and cancer diagnostics; diagnostic preparations for medical purposes; diagnostic preparations for in-vitro testing for medical use; pharmaceuticals, pharmaceutical preparations, medical products in the nature of diagnostic preparations, medical preparations, chemical products in the nature of chemical reagents, chemical preparations, biochemical products in the nature of chemical reagents, and biochemical preparations, all for use in chemotherapy and cancer diagnotics for medical use; pharmaceutical, medical, chemical and biochemical preparations for medical purposes in the fields of histology, cytology, immunohistology, immunohistochemistry, in situ hybridisation, polymerase chain reaction (PCR), next generation sequencing (NGS), microarray hybridisation in the nature of genetic chip or biochip hybridisation, flow cytometry services, and isolation of biomolecules including DNA, RNA and proteins; nucleic acids in the natu...

Business management consultancy and advisory services; operation of a business for others, namely, holding company services; holding company services performed for third parties, namely, business management, business administration, providing office functions; holding company services performed for third parties, namely developing marketing strategy, professional business and organisational consultancy and management of the business interests of others and legally independent companies; business management and organization consultancy; advisory services for business management; business administration; providing office functions; planning and monitoring of business developments with regard to organisational matters in the nature of business organisational consultation

Chemicals for use in industry and science; chemicals and biochemicals for use in science in the fields of pathology, genetics, human genetics, molecular pathologies, molecular biology, microbiology, biotechnology, laboratory medicine; chemicals and biochemicals for use in science in the fields of histology, cytology, immunohistology, immunohistochemistry, in situ hybridisation, polymerase chain reaction (PCR), next generation sequencing (NGS), microarray hybridisation in the nature of genetic chip or biochip hybridisation, flow cytometry services, and isolation of biomolecules including DNA, RNA and proteins; nucleic acids in the nature of DNA, RNA, oligonucleotides, polynucleotides, marked nucleic acids and modified nucleic acids, for scientific purposes; proteins in the nature of peptide substrates, recombinant proteins and marked proteins for scientific and medical research; antibodies for scientific purposes; DNA probes being biochemical preparations for scientific purposes; RNA pr...

Medical services; medical diagnostic services; medical in-vitro diagnostic services for medical and pharmaceutical purposes; medical services in the fields of pathology, genetic science, human genetics, molecular pathologies, molecular biology, microbiology, biotechnology and laboratory medicine; medical diagnostic services using histology, cytology, immunohistology, immunohistochemistry, in situ hybridisation, polymerase chain reaction (PCR), next generation sequencing (NGS), microarray hybridisation in the nature of genetic chip or biochip hybridisation, flow cytometry and isolation of biomolecules including DNA, RNA and proteins; medical counseling; pharmaceutical services in the nature of developing pharmaceuticals for diagnosing and treating cancer; pharmaceutical advice; medical and health clinic services relating to DNA, genetics and genetic testing; medical pathology services; genetic testing for medical purposes

Medical apparatus and instruments for use in cancer diagnostic and treatment procedures; medical instruments for use in cancer diagnostic and treatment procedures; medical analytical apparatus for analyzing human cells and tissues for the presence of cancerous cells for medical purposes; automatic analyzers for medical diagnosis of human cells and tissues; physical analyzers for diagnosing cancer for medical use; genetic testing apparatus for medical purposes

Science and technology services, namely, research in the field of cancer; medical research laboratory services; development of pharmaceutical preparations and medicines; clinical research in the field of cancer diagnosis and treatment for medical and scientific purposes; research relating to biotechnology; scientific research consultancy services; biological analysis, biochemical analysis, chemical analysis, scientific analysis, all being scientific research; scientific research in the field of genetics and genetic engineering
zytomics

General Information


Serial Number79391171
Word MarkZYTOMICS
Filing DateWednesday, November 1, 2023
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateThursday, March 6, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesScientific research and laboratory apparatus in the nature of analysis systems for use in the analysis of proteins, nucleic acids, human cells, and human tissues; educational apparatus and simulators in the nature of medical diagnostic simulators for use as teaching aids for medical procedures; analysis apparatus in the nature of diagnostic apparatus for research laboratory use for conducting and evaluating histology, cytology, immunohistology, immunohistochemistry, in situ hybridisation, polymerase chain reaction (PCR), next generation sequencing (NGS), microarray hybridisation in the nature of genetic chip or biochip hybridisation, flow cytometry, and isolation of biomolecules including DNA, RNA and proteins; research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids; analysis apparatus for research laboratories in the nature of diagnostic apparatus for measuring, testing and examining tissue, cells and biomolecules including DNA, RNA and proteins
Goods and ServicesPharmaceuticals and medical preparations for use in chemotherapy and cancer diagnostics; diagnostic preparations for medical purposes; diagnostic preparations for in-vitro testing for medical use; pharmaceuticals, pharmaceutical preparations, medical products in the nature of diagnostic preparations, medical preparations, chemical products in the nature of chemical reagents, chemical preparations, biochemical products in the nature of chemical reagents, and biochemical preparations, all for use in chemotherapy and cancer diagnotics for medical use; pharmaceutical, medical, chemical and biochemical preparations for medical purposes in the fields of histology, cytology, immunohistology, immunohistochemistry, in situ hybridisation, polymerase chain reaction (PCR), next generation sequencing (NGS), microarray hybridisation in the nature of genetic chip or biochip hybridisation, flow cytometry services, and isolation of biomolecules including DNA, RNA and proteins; nucleic acids in the nature of DNA, RNA, oligonucleotides, polynucleotides, marked nucleic acids and modified nucleic acids for medical purposes; proteins in the nature of peptide substrates, recombinant proteins and marked proteins for use in chemotherapy and cancer diagnostics for medical purposes; antibodies for medical purposes; DNA probes being biochemical preparations for chemotherapy and cancer diagnostics for medical use; RNA probes being biochemical preparations for chemotherapy and cancer diagnostics for medical use; oligonucleotide probes being biochemical preparations for chemotherapy and cancer diagnostics for medical use; biological tissue, namely, human stem cells, human somatic cells, human cancer cells, human tissue, and human tissue sections for use in chemotherapy and cancer diagnostics; nucleic acids, proteins,human somatic cells, human cancer cells and human stem cells immobilised on carriers for medical diagnostic purposes
Goods and ServicesBusiness management consultancy and advisory services; operation of a business for others, namely, holding company services; holding company services performed for third parties, namely, business management, business administration, providing office functions; holding company services performed for third parties, namely developing marketing strategy, professional business and organisational consultancy and management of the business interests of others and legally independent companies; business management and organization consultancy; advisory services for business management; business administration; providing office functions; planning and monitoring of business developments with regard to organisational matters in the nature of business organisational consultation
Goods and ServicesChemicals for use in industry and science; chemicals and biochemicals for use in science in the fields of pathology, genetics, human genetics, molecular pathologies, molecular biology, microbiology, biotechnology, laboratory medicine; chemicals and biochemicals for use in science in the fields of histology, cytology, immunohistology, immunohistochemistry, in situ hybridisation, polymerase chain reaction (PCR), next generation sequencing (NGS), microarray hybridisation in the nature of genetic chip or biochip hybridisation, flow cytometry services, and isolation of biomolecules including DNA, RNA and proteins; nucleic acids in the nature of DNA, RNA, oligonucleotides, polynucleotides, marked nucleic acids and modified nucleic acids, for scientific purposes; proteins in the nature of peptide substrates, recombinant proteins and marked proteins for scientific and medical research; antibodies for scientific purposes; DNA probes being biochemical preparations for scientific purposes; RNA probes being biochemical preparations for scientific purposes; oligonucleotide probes being biochemical preparations for scientific purposes; biological tissue, namely, human stem cells, human somatic cells, human cancer cells, human tissue, human tissue sections, for scientific and medical research; nucleic acids, proteins, human somatic cells, human cancer cells, and stem cells immobilised on carriers for scientific and medical research
Goods and ServicesMedical services; medical diagnostic services; medical in-vitro diagnostic services for medical and pharmaceutical purposes; medical services in the fields of pathology, genetic science, human genetics, molecular pathologies, molecular biology, microbiology, biotechnology and laboratory medicine; medical diagnostic services using histology, cytology, immunohistology, immunohistochemistry, in situ hybridisation, polymerase chain reaction (PCR), next generation sequencing (NGS), microarray hybridisation in the nature of genetic chip or biochip hybridisation, flow cytometry and isolation of biomolecules including DNA, RNA and proteins; medical counseling; pharmaceutical services in the nature of developing pharmaceuticals for diagnosing and treating cancer; pharmaceutical advice; medical and health clinic services relating to DNA, genetics and genetic testing; medical pathology services; genetic testing for medical purposes
Goods and ServicesMedical apparatus and instruments for use in cancer diagnostic and treatment procedures; medical instruments for use in cancer diagnostic and treatment procedures; medical analytical apparatus for analyzing human cells and tissues for the presence of cancerous cells for medical purposes; automatic analyzers for medical diagnosis of human cells and tissues; physical analyzers for diagnosing cancer for medical use; genetic testing apparatus for medical purposes
Goods and ServicesScience and technology services, namely, research in the field of cancer; medical research laboratory services; development of pharmaceutical preparations and medicines; clinical research in the field of cancer diagnosis and treatment for medical and scientific purposes; research relating to biotechnology; scientific research consultancy services; biological analysis, biochemical analysis, chemical analysis, scientific analysis, all being scientific research; scientific research in the field of genetics and genetic engineering

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateThursday, March 14, 2024
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, March 14, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus.
US Class Codes021, 023, 026, 036, 038
Class Status Code6 - Active
Class Status DateThursday, March 14, 2024
Primary Code009
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, March 14, 2024
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateThursday, March 14, 2024
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, March 14, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, March 14, 2024
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameZytoVision GmbH
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDE

Trademark Events


Event DateEvent Description
Thursday, March 14, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, March 22, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, April 24, 2024APPLICATION FILING RECEIPT MAILED
Thursday, May 30, 2024ASSIGNED TO EXAMINER
Friday, May 31, 2024NON-FINAL ACTION WRITTEN
Tuesday, June 4, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, June 4, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, June 4, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, January 22, 2025NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, June 4, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, December 27, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, January 22, 2025REFUSAL PROCESSED BY MPU
Sunday, February 9, 2025REFUSAL PROCESSED BY IB
Thursday, March 6, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 6, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 6, 2025TEAS/EMAIL CORRESPONDENCE ENTERED